BioVaxys Announces Results from The Ohio State University Pan-Sarbecovirus Animal Study
VANCOUVER, BC, Dec. 16, 2022 /CNW/ -- BioVaxys Technology Corp. BIOV 5LB BVAXF ("BioVaxys" or "Company") announced today that possibly based on the selected study design, results from The Ohio State University ("Ohio State") …